Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

PURPOSE: Most patients with breast cancer age ≥ 65 years (ie, older patients) are eligible for adjuvant hormonal therapy, but use is not universal. We examined the influence of frailty on hormonal therapy noninitiation and discontinuation. PATIENTS AND METHODS: A prospective cohort of 1,288 older wo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sheppard, Vanessa B., Faul, Leigh Anne, Luta, George, Clapp, Jonathan D., Yung, Rachel L., Wang, Judy Huei-yu, Kimmick, Gretchen, Isaacs, Claudine, Tallarico, Michelle, Barry, William T., Pitcher, Brandelyn N., Hudis, Clifford, Winer, Eric P., Cohen, Harvey J., Muss, Hyman B., Hurria, Arti, Mandelblatt, Jeanne S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2014
Onderwerpen:
ORIGINAL REPORTS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4105485/
https://ncbi.nlm.nih.gov/pubmed/24934786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.51.7367
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items